Last quarter (Q ), CureVac's total revenue was €―, a decrease of -100.00% from the same quarter last year. In Q, CureVac's net income was €―. See CureVac’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	€ 55.73M	€ 67.42M	€ 102.99M	€ 48.87M	€ 17.42M	€ 12.87M
Cost of Revenue	€ 103.99M	€ -183.99M	€ 238.19M	€ 14.17M	€ 27.98M	€ 17.74M
Gross Profit	€ -48.26M	€ -116.57M	€ -135.21M	€ 34.70M	€ -10.57M	€ -4.87M
Operating Expense	€ 80.61M	€ 174.52M	€ 919.26M	€ 144.51M	€ 88.93M	€ 67.95M
Operating Income	€ -128.87M	€ -291.10M	€ -1.05B	€ -109.81M	€ -99.50M	€ -72.82M
Net Non Operating Interest Income Expense	€ 7.54M	€ 4.01M	€ 10.10M	€ -20.03M	€ -627.00K	€ 1.69M
Other Income Expense	-	€ 105.00K	€ -574.41M	-	-	-
Pretax Income	€ -120.41M	€ -249.16M	€ -480.29M	€ -129.85M	€ -100.13M	€ -71.13M
Tax Provision	€ -160.00K	€ -126.00K	€ -782.00K	€ -726.00K	€ -252.00K	€ 110.00K
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	€ -120.25M	€ -287.07M	€ -479.51M	€ -129.12M	€ -99.87M	€ -71.24M
Basic EPS	€ -0.64	€ -1.32	€ -2.21	€ -0.98	€ -0.57	€ -0.40
Diluted EPS	€ -0.64	€ -1.32	€ -2.21	€ -0.98	€ -0.57	€ -0.40
Basic Average Shares	€ 564.06M	€ 189.07M	€ 186.01M	€ 132.20M	€ 175.97M	€ 175.97M
Diluted Average Shares	€ 564.06M	€ 217.47M	-	€ 132.20M	€ 175.97M	€ 175.97M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	€ 184.60M	€ -9.47M	€ 1.16B	€ 158.69M	€ 116.91M	€ 85.69M
Net Income From Continuing And Discontinued Operation	€ -120.25M	€ -287.07M	€ -479.51M	€ -129.12M	€ -99.87M	€ -71.24M
Normalized Income	€ -120.25M	-	-	€ -129.12M	€ -99.87M	€ -71.24M
Interest Expense	€ 3.08M	-	-	€ 22.10M	€ 1.46M	€ 275.00K
EBIT	€ -117.33M	€ -249.16M	€ -490.39M	€ -107.75M	€ -98.67M	€ -70.86M
EBITDA	€ -93.98M	€ -225.41M	€ -474.72M	€ -97.07M	€ -91.50M	€ -67.08M

Currency in EUR

CureVac Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing